Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1912-1919

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hara, T.
Right arrow Articles by Hossmann, K.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hara, T.
Right arrow Articles by Hossmann, K.-A.
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Brain Circulation and Metabolism
Right arrow Embolic stroke
Right arrow Thrombolysis

(Stroke. 2001;32:1912.)
© 2001 American Heart Association, Inc.


Original Contributions

Gene Expressions After Thrombolytic Treatment of Middle Cerebral Artery Clot Embolism in Mice

Takayuki Hara, MD; Günter Mies, MD; Ryuji Hata, MD Konstantin-Alexander Hossmann, MD, PhD

From the Department of Experimental Neurology (T.H., G.M., K.-A.H.), Max-Planck-Institute for Neurological Research, Cologne, Germany; and Department of Anatomy and Neuroscience (R.H.), Ehime University School of Medicine, Ehime, Japan.

Correspondence to Prof Dr K.-A. Hossmann, Max-Planck-Institute for Neurological Research, Department of Experimental Neurology, Gleueler Str 50, D-50931 Cologne, Germany. E-mail Hossmann{at}mpin-koeln.mpg.de

Background and Purpose—— Thrombolytic treatment of stroke may result in reperfusion injury. To investigate the role of selective gene expressions, C57Bl/6J mice were subjected to middle cerebral artery (MCA) clot embolism, followed after 1 hour by intracarotid infusion of 10 mg/kg recombinant tissue plasminogen activator (rtPA) or vehicle.

Methods—— Before the onset of treatment and at 1, 3, 6, and 24 hours of recirculation, animals were frozen in situ and hsp70, c-fos, junB, and NSE mRNAs were imaged on cryostat sections using in situ hybridization autoradiography. Cerebral protein synthesis (CPS) and ATP content were measured on adjacent brain sections.

Results—hsp70 mRNA was upregulated in the penumbral cortex of untreated animals and in the MCA core region of animals receiving rtPA (ie, regions characterized by a mismatch between high ATP levels and suppressed CPS). c-fos and junB mRNAs were transiently expressed mainly in the peri-infarct intact cortex for up to 3 to 6 hours in the treated and up to 24 hours in the untreated animals. In both groups, NSE mRNA declined in the central parts of the MCA territory together with a loss of silver impregnation, but this decline was more pronounced in the untreated animals.

Conclusions—— The genomic expression pattern after thrombolytic recanalization of clot embolism resembles that of other types of transient ischemia such as reversible thread occlusion, although the outcome is markedly different. The investigated gene expressions, notably hsp70 mRNA, reflect the kind and severity of the ischemic stress, but they do not predict reversibility of the ischemic injury.


Key Words: cerebral ischemia, focal • gene expression • stress genes • thrombolysis




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. Dash, I. P. Maine, S. Varambally, R. Shen, A. M. Chinnaiyan, and M. A. Rubin
Changes in Differential Gene Expression because of Warm Ischemia Time of Radical Prostatectomy Specimens
Am. J. Pathol., November 1, 2002; 161(5): 1743 - 1748.
[Abstract] [Full Text] [PDF]